GSK recalls 600,000 Ventolin Inhalers from US

GSK recalls 600,000 Ventolin Inhalers from US

Multinational pharmaceutical company, GlaxoSmithKline (GSK) has announced the recall of over 590,000 Salbutamol  (Ventolin) inhalers from the US market, saying there could be issues with the delivery technique.

The recall is for three lots of Ventolin HFA 200D inhalers with lot numbers 6ZP0003, 6ZP9944 and 6ZP9848.

The inhalers, according to reports,  have been distributed to hospitals, pharmacies, retailers and wholesalers in the United States.

“There is attainable risk that the affected inhalers could potentially not deliver the stated number of actuations,” according to GSK spokesman Juan Carlos Molina. “We continue to investigate the situation in order to identify the root lead to and implement appropriate corrective and preventative actions.”

The recall is not directed at individuals, but those with inhalers from the recalled lots have been advised to contact the company.

About author

You might also like

NAFDAC alerts on fake Ampicillin/Cloxacillin

The National Agency for Food and Drugs Administration and Control (NAFDAC) has alerted the public against falsified antibiotic combination of Ampicillin/cloxacillin in circulation in the country. The agency, in the

PHARMA NEWS 0 Comments

Johnson & Johnson recalls baby powder as asbestos trace is discovered in one bottle

World’s largest healthcare company, Johnson & Johnson on Friday, (October 18) recalled a single batch of its baby powder as a precaution after government testing found trace amounts of asbestos

BREAKING NEWS 0 Comments

Nigeria is far behind in modern cancer treatment  –  Indian Cancer specialist

A renowned Indian radiation oncologist (specialist in cancer treatment) Dr. Madhusudhan, currently on a visit to the country, says Nigeria is still lagging behind in the use of  modern technologies

0 Comments

No Comments Yet!

You can be first to comment this post!

Leave a Reply